Logo
x

Search

Subscribe Now

Launches

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

  • October 26, 2021
Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada

Sandoz Launches Inclunox and Inclunox HP (biosimilar- enoxaparin sodium solution) in Canada

  • May 17, 2021
Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada

Amgen Launches Amgevita (biosimilar- adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada

  • May 5, 2021
Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

Omada Health Launches the First Virtual Cardiometabolic Clinic for Patients with Diabetes and Hypertension

  • April 16, 2021
Medtronic Launches World's First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

Medtronic Launches World's First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

  • April 15, 2021
Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada

  • April 15, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.